These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30301694)

  • 21. Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
    Sivaraman A; Benfante N; Touijer K; Coleman J; Scardino P; Laudone V; Eastham J
    Investig Clin Urol; 2018 Mar; 59(2):83-90. PubMed ID: 29520383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage lymphadenectomy after primary therapy with curative intent for prostate cancer.
    Quhal F; Bryniarski P; Rivas JG; Gandaglia G; Shariat SF; Rajwa P
    Curr Opin Urol; 2023 Jul; 33(4):269-273. PubMed ID: 37166270
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Li TC; Wang Y; Xiao CT; Li MZ; Liu XP; Huang WT; Li LY; Li K; Di JM; Wen XQ; Gao X
    Asian J Androl; 2022; 24(1):97-101. PubMed ID: 34213490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo neurogenic bladder dysfunction after salvage lymph node dissection in patients with nodal recurrence of prostate cancer.
    Hanske J; Müller G; van Ophoven A; von Landenberg N; Roghmann F; Palisaar RJ; von Bodman C; Noldus J; Brock M
    Neurourol Urodyn; 2018 Aug; 37(6):1988-1995. PubMed ID: 29504654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate Cancer Following Radical Prostatectomy.
    Milenkovic U; Kuijk J; Roussel E; Devos G; Van den Broeck T; Van Eecke H; Vanderstichele A; Duvillier T; Verhamme L; Van Haute W; Goeman L; Berghen C; Joniau S; De Meerleer G
    Eur Urol Oncol; 2023 Dec; 6(6):582-589. PubMed ID: 36878753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery.
    Knipper S; Mehdi Irai M; Simon R; Koehler D; Rauscher I; Eiber M; van Leeuwen FWB; van Leeuwen P; de Barros H; van der Poel H; Budäus L; Steuber T; Graefen M; Tennstedt P; Heck MM; Horn T; Maurer T
    Eur Urol; 2023 Jan; 83(1):62-69. PubMed ID: 35718637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes.
    Gandaglia G; Soligo M; Battaglia A; Muilwijk T; Robesti D; Mazzone E; Barletta F; Fossati N; Moschini M; Bandini M; Joniau S; Karnes RJ; Montorsi F; Briganti A
    Eur Urol; 2019 May; 75(5):817-825. PubMed ID: 30409676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.
    Ploussard G; Gandaglia G; Borgmann H; de Visschere P; Heidegger I; Kretschmer A; Mathieu R; Surcel C; Tilki D; Tsaur I; Valerio M; van den Bergh R; Ost P; Briganti A;
    Eur Urol; 2019 Oct; 76(4):493-504. PubMed ID: 30391078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage lymph node dissection in hormone-naïve men: How effective is surgery?
    Hanske J; Ostholt J; Roghmann F; Müller G; Braun K; Gomez B; von Landenberg N; von Bodman C; Palisaar RJ; Liermann D; Noldus J; Brock M
    Urol Oncol; 2019 Nov; 37(11):812.e17-812.e24. PubMed ID: 31327750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.
    Briganti A; Karnes RJ; Joniau S; Boorjian SA; Cozzarini C; Gandaglia G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Sun M; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
    Eur Urol; 2014 Sep; 66(3):479-86. PubMed ID: 24345725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis.
    Fossati N; Parker WP; Karnes RJ; Colicchia M; Bossi A; Seisen T; Di Muzio N; Cozzarini C; Noris Chiorda B; Fiorino C; Gandaglia G; Bartkowiak D; Wiegel T; Shariat S; Goldner G; Battaglia A; Joniau S; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A; Boorjian SA
    Eur Urol; 2018 Aug; 74(2):134-137. PubMed ID: 29544737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of
    Mandel P; Tilki D; Chun FK; Pristupa E; Graefen M; Klutmann S; Budäus L; Steuber T
    Eur Urol Focus; 2020 Jan; 6(1):71-73. PubMed ID: 30049657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
    Karnes RJ; Murphy CR; Bergstralh EJ; DiMonte G; Cheville JC; Lowe VJ; Mynderse LA; Kwon ED
    J Urol; 2015 Jan; 193(1):111-6. PubMed ID: 25150640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management.
    Linxweiler J; Sprenk J; Cascetta K; Pryalukhin A; Hölters S; Zeuschner P; Nini A; Al-Kailani Z; Ezziddin S; Bohle RM; Fries P; Ohlmann CH; Heinzelbecker J; Siemer S; Stöckle M; Junker K; Saar M
    J Urol; 2021 Jul; 206(1):88-96. PubMed ID: 33617326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
    Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET.
    Farolfi A; Ilhan H; Gafita A; Calais J; Barbato F; Weber M; Afshar-Oromieh A; Spohn F; Wetter A; Rischpler C; Hadaschik B; Pianori D; Fanti S; Haberkorn U; Eiber M; Herrmann K; Fendler WP
    J Nucl Med; 2020 Jul; 61(7):1037-1042. PubMed ID: 31806773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage lymph node dissection in patients with prostate cancer treated with radical prostatectomy or radiotherapy and positive choline positron emission tomography (PET/CT) scan.
    Otta-Oshiro RJ; Lista-Mateos F; García-Mediero J; Arranz-Arija JA; García-Prado J; Núñez-Mora C
    Actas Urol Esp (Engl Ed); 2019; 43(6):331-335. PubMed ID: 30975547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of positive lymph nodes following radical prostatectomy.
    Heidenreich A; Rieke M; Mahjoub S; Pfister D
    Arch Esp Urol; 2019 Mar; 72(2):182-191. PubMed ID: 30855020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.
    Bravi CA; Heidenreich A; Fossati N; Gandaglia G; Suardi N; Mazzone E; Stabile A; Cucchiara V; Osmonov D; Juenemann KP; Karnes RJ; Kretschmer A; Buchner A; Stief C; Hiester A; Albers P; Devos G; Joniau S; Van Poppel H; Grubmüller B; Shariat S; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A; Pfister D
    BJUI Compass; 2023 Jan; 4(1):123-129. PubMed ID: 36569505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage lymph node dissection after
    Herlemann A; Kretschmer A; Buchner A; Karl A; Tritschler S; El-Malazi L; Fendler WP; Wenter V; Ilhan H; Bartenstein P; Stief CG; Gratzke C
    Oncotarget; 2017 Oct; 8(48):84180-84192. PubMed ID: 29137414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.